Susanna Tokola

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E L Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Outi Kuittinen
Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors. Cancer medicine 13 (1) (2024)
Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E L Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Outi Kuittinen
Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors. Cancer medicine (2024)
Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E L Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Outi Kuittinen
Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors. Cancer medicine (2024)
Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E L Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Outi Kuittinen
Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors. Cancer medicine (2024)
Susanna Tokola, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Outi Kuittinen
Interim and end-of-treatment PET-CT suffers from high false-positive rates in DLBCL: Biopsy is needed prior to treatment decisions. Cancer medicine 10 (9) (2021)
Susanna Tokola, Hanne Kuitunen, Taina Turpeenniemi-Hujanen, Outi Kuittinen
Significance of bulky mass and residual tumor-Treated with or without consolidative radiotherapy-To the risk of relapse in DLBCL patients. Cancer medicine 9 (6) (2020)